Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle B
Phase 1Terminated 0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Interdigital Tinea Pedis
Conditions
Interdigital Tinea Pedis
Trial Timeline
Jul 1, 2010 → Jul 1, 2011
NCT ID
NCT01119742About Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle B
Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle B is a phase 1 stage product being developed by Sun Pharmaceutical for Interdigital Tinea Pedis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01119742. Target conditions include Interdigital Tinea Pedis.
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01119742 | Phase 1 | Terminated |